Muvalaplin (LY3473329)
Kwaliteit
ISO Gecertificeerd
Levering
24-48 uur
Technische Specificaties
2565656-70-2
LY3473329
Others
Others
C42H54N4O6
Muvalaplin (LY3473329) is an orally administered small molecule that inhibits lipoprotein (a) (Lp (a) ) formation by blocking the apo (a) -apo B100 interaction. It can be used in research of atherosclerotic disease and aortic stenosis.
Beschrijving
Muvalaplin (LY3473329) Beschikbaar in 25 mg. Bestel eenvoudig online met snelle levering.
Specificaties
Recent bekeken producten
Simulated Dermal Fluid (BZ457) - 100 mL
BZ457-01
100 mL
Polyclonal BDNF Antibody
APG02253G
0.05mg
Biotin-Recombinant (sf9) Marburg virus glycoprotein (Musoke, HA-tag, >95%), purified
MVGP16-BTN
100 µL
MARV VP40/Marburg VP40 Protein (N-His, Lake Victoria marburgvirus (strain Musoke-80) (MARV) (Marburg virus (strain Kenya/Musoke/1980) ) )
P505862
100 µg
Hettich Centrifuge Rotanta 460R Refrigerated Large Volume
CEN0703
1 Each
X4RF Refrigerated Centrifuge
75009936
1 Each
Drug Stability Chamber
500-DSC102
1 Unit
Modular Incubator Chamber
MIC-101
1 Unit
Recent gezochte producten
Dried Body Fluids DNA Purification Kit
K1464-250
250 Preparations
Dried Body Fluids DNA Purification Kit
K1464-50
50 Preparations
Simulated Bile Juice (BZ263) - 100 mL
BZ263-01
100 mL
Simulated Blood Serum (BZ278) - 100 mL
BZ278-01
100 mL
Simulated Blood Matrix (BZ281) - 100 mL
BZ281-01
100 mL
Simulated Body Fluid Corrected (c-SBF) (BZ310) - 100 mL
BZ310-01
100 mL
Simulated Body Fluid (SBF) ISO 23317 Method - 1000mL
BZ361-01
100 mL
Simulated Bone Marrow Medium (BZ373) - 100 mL
BZ373-01
100 mL